The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline.
The CRAFFT screening tool has acceptable concurrent and predictive value for substance use and substance use disorders in youth who visit pediatric emergency departments, and has value in predicting substance use disorders at follow-up.
Early-onset psychiatric comorbidity was primarily associated with increased risk for natural death in adults with ADHD, while later-onset psychiatric comorbidity was more often associated with death due to such causes as suicide and unintentional injury.
The prevalence of cluster headache may be higher in individuals with a substance use disorder than in the general population.
Expanded Medicaid eligibility thresholds were associated with a reduction in substance use disorder-related deaths during the current US opioid epidemic.
Hearing loss is independently associated with substance use disorders among those aged 49 years and younger.
Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.
Physicians reported that a lack of training in brief intervention and reimbursement make providing screening and intervention more difficult when caring for youth with possible substance use disorders.
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
From 2007 to 2016, there was an increase in the proportion of substance use treatment facilities offering medication treatment.